LAKEWOOD, Colo.--(BUSINESS WIRE)--Gambro BCT, Inc., soon to be known as CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies, announced today that it received FDA clearance for the commercial sale of Atreus® Whole Blood Processing system in the United States. The Atreus system is the first self-contained, automated manufacturing system cleared for distribution in the U.S.